Head & Neck Cancer section

Head and Neck Cancer News & Features

Cancer Cachexia Associated With Poor Outcomes

Cancer Cachexia Associated With Poor Outcomes

Findings at 6 and 12 months after treatment for advanced head and neck cancer indicate a higher risk of recurrences for those reporting cachexia after their treatment.

Uric Acid May Mark Progression for Nasopharyngeal Cancer

Uric Acid May Mark Progression for Nasopharyngeal Cancer

High pretreatment uric acid may be a clinical biomarker for lung metastasis.

Stepped Psychological Care for Patients with Head and Neck or Lung Cancer

Stepped Psychological Care for Patients with Head and Neck or Lung Cancer

For patients with head and neck or lung cancer, stepped care programs may offer a more affordable yet effective approach.

Panitumumab Plus Accelerated RT Not Effective for Locoregionally Advanced HNSCC

Panitumumab Plus Accelerated RT Not Effective for Locoregionally Advanced HNSCC

Progression-free survival with panitumumab plus accelerated-fractionation radiotherapy was compared with that of cisplatin plus standard-fractionation radiotherapy in patients with locoregionally advanced HNSCC in a recently published study.

USPSTF Continues Recommendations Against Thyroid Cancer Screening

USPSTF Continues Recommendations Against Thyroid Cancer Screening

Widespread routine thyroid cancer screening can lead to overdiagnosis and overtreatment, the USPSTF contends.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs